Key result
Medication non-adherence is associated with higher risk of CVD hospitalization in African Americans.
Why the study?
Non-adherence to prescribed cardiovascular medications is a pervasive problem that negatively affects treatment outcomes, prompting an examination of the association between demographic parameters, medication adherence behaviors, and health outcomes in African Americans.
Cohort (n=5,301)
No
Answers are grounded in this paper and cite their sources.
Epidemiological study reveals cardiovascular medication adherence gaps and hospitalization risks in African Americans, highlighting key barriers to treatment compliance.
Even though some medications have the potential to slow the progress of atherosclerosis and development of CVD, there are many at-risk individuals who continue to resist the benefits that are available by not following the advice of medical professionals. Non-adherence to prescribed drug regimens is a pervasive medical problem that negatively affects treatment outcomes. Information from standardized interviews of 5301 African Americans participating in the Jackson Heart Study was examined to determine the association between demographic parameters, behavior including adherence to prescribed medical regimens, and health outcomes. Data were also collected at Annual Follow-Up and Surveillance visits. During the two weeks prior to the examination visit, almost 52% of the participants reported taking blood pressure medication, 14% took cholesterol medication, 16% took medication for diabetes, and 19% took blood thinning medication. Of those who did not take the prescribed medications, the reasons given were the following: 47% were in a hurry, too busy, or forgot to take medications; 23% were trying to do without medications; 18% had no money to purchase medications; 19% indicated that the medications made them feel bad; 17% felt that they could not carry out daily functions when taking medications. The African American population can benefit from heightened awareness of the risk factors that are associated with CVD and the benefits of following a prescribed treatment regimen. Unacceptable secondary effects of prescribed medication comprised an important cause of non-compliance. Encouragement of this population to communicate with their healthcare providers to ensure that medication regimens are better tolerated could increase compliance and improve health outcomes.
No takes yet. Share an insight, caveat, or question.
Addison et al. (2011) conducted a cohort in Cardiovascular disease and related risk factors (hypertension, high cholesterol, diabetes, heart attack, stroke) (n=5,301). Medication adherence to prescribed cardiovascular disease regimens vs. Medication non-adherence was evaluated on Self-reported hospitalization for cardiovascular disease during the previous 12 months (p=<0.05). Medication adherence in 5,301 African Americans was high for hypertension and diabetes but low for heart problems, with non-adherence predicting CVD hospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: